Annual report pursuant to Section 13 and 15(d)

Accrued Expenses (Detail)

v3.20.4
Accrued Expenses (Detail) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Accrued Liabilities Current [Abstract]    
External research and preclinical development $ 4,702 $ 5,395
Employee compensation and benefits 5,715 4,174
Professional fees 602 694
Facilities and other 65 383
Total accrued expenses $ 11,084 $ 10,646